Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
June 19, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002295.pdf 0001562180-17-002295.rtf 0001562180-17-002295.xls View HTML
June 19, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002296.pdf 0001562180-17-002296.rtf 0001562180-17-002296.xls View HTML
June 19, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002292.pdf 0001562180-17-002292.rtf 0001562180-17-002292.xls View HTML
June 19, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002293.pdf 0001562180-17-002293.rtf 0001562180-17-002293.xls View HTML
June 19, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002290.pdf 0001562180-17-002290.rtf 0001562180-17-002290.xls View HTML
June 19, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002291.pdf 0001562180-17-002291.rtf 0001562180-17-002291.xls View HTML
June 2, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002141.pdf 0001562180-17-002141.rtf 0001562180-17-002141.xls View HTML
June 1, 2017	3	Initial filing by director officer or owner of more than ten percent.	0001562180-17-002107.pdf 0001562180-17-002107.rtf 0001562180-17-002107.xls View HTML
May 25, 2017	8-K	Report of unscheduled material events or corporate event	0001193125-17-182645.pdf 0001193125-17-182645.rtf 0001193125-17-182645.xls View HTML
May 22, 2017	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-17-178026.pdf 0001193125-17-178026.rtf 0001193125-17-178026.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax